How does a company with a lead asset cancer drug also get into dermatology? What does blood cancer and keloid…
The skin is one of the most overlooked, complex and essential organs. It is the body’s first line of defence…
Clinical stage pharmaceutical company Pharmaxis (PXS: ASX) is full steam ahead with their Phase 2 clinical trial for flagship drug,…
The pharmaceutical industry is an incredibly competitive space with new drug discoveries cropping up all the time, giving hope that…
In the wake of their oversubscribed capital raising effort, clinical stage pharmaceutical company Pharmaxis (ASX: PXS) is forging ahead with…
Just days after closing their oversubscribed $9.8 million capital raise, drug developer Pharmaxis (ASX: PXS) has seen further funding devoted…